Use of Genetic Testing to Guide the Initiation of Warfarin Therapy

Does Not Meet CTAF Criteria

This topic was reviewed by the California Technology Assessment Forum on March 5, 2008.

It was recommended that the use of genetic testing to guide initial warfarin dosing does not meet Technology Assessment Criteria 3 through 5 for safety, effectiveness and improvement in health outcomes.


Full Assessment:

Download (PDF, 282 KB)

Search Assessments

Email Notification

Sign up to receive email notifications of upcoming CTAF meetings and new assessments.

 

Methodology

Learn about the CTAF criteria used to evaluate a new or emerging technology.

Criteria used »
Assessment Process »
Format of Report »

Suggest an Assessment

Know of a new device, procedure, or test that CTAF should consider for assessment?

Contact us »
 
© 2008 California Technology Assessment Forum. All rights reserved.

Contact Us | Privacy Policy | Terms of Use | Credits